Ionis Pharmaceuticals, Inc. Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss
Ionis Pharmaceuticals, Inc. (IONS) had Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss of $0 as of 2020-09-30, per its 10-Q filed 2020-11-04.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss · last filed 2020-11-04
- 2020-09-30: Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss $0.00.
- 2020-06-30: Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss $4.00K.
- 2020-03-31: Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss $11.00K.
- 2019-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss $41.00K.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss |
|---|---|
| 2020-09-30 | $0.00 10-Q · filed 2020-11-04 |
| 2020-06-30 | $4.00K 10-Q · filed 2020-08-05 |
| 2020-03-31 | $11.00K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $41.00K 10-K · filed 2020-03-02 |
| 2019-09-30 | $99.00K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $278.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $926.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $1.91M 10-K · filed 2019-03-01 |
| 2018-09-30 | $1.83M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $1.19M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $1.26M 10-Q · filed 2018-05-07 |
| 2017-12-31 | $1.01M 10-K · filed 2018-02-28 |
| 2017-09-30 | $637.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $106.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $129.00K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $223.00K 10-K · filed 2017-03-01 |
| 2016-09-30 | $474.00K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $258.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $120.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $206.00K 10-K · filed 2016-02-26 |
| 2015-09-30 | $124.00K 10-Q · filed 2015-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |